Company Overview
Snapshot
Founded in December 2017 by Doron Bushi, FastBreak Medical operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on developing its noninvasive wearable sensing patch for early detection of carotid stenosis, a critical risk factor for stroke.
Business overview
FastBreak Medical develops a noninvasive wearable sensing patch designed for the early detection of carotid stenosis, a significant risk factor for stroke. The technology involves a patch attached to the neck above the carotid artery, which monitors blood pressure waveforms in near-surface arteries to identify abnormal carotid pulse waves associated with carotid stenosis. The device utilizes wireless Bluetooth communication to transmit data to a user's application for analysis, targeting the digital healthcare and medical devices sectors with a focus on diagnostics and monitoring.
Log in to access full profile ›Company Intelligence Q&A
- What is FastBreak Medical's core product?
- FastBreak Medical develops a noninvasive wearable sensing patch for the early detection of carotid stenosis, a risk factor for stroke. The patch monitors blood pressure waveforms and detects abnormal carotid pulse waves.
- When was FastBreak Medical founded?
- FastBreak Medical was founded in December 2017.
- Who founded FastBreak Medical?
- FastBreak Medical was founded by Doron Bushi, who serves as the Founder & CEO.
- What stage is FastBreak Medical currently in?
- FastBreak Medical is currently in the Pre-Funding stage, with its product in clinical trial.
- What technology does FastBreak Medical's device use for data transfer?
- FastBreak Medical's patch uses wireless Bluetooth communication to transfer data to a user's application for analysis.